- Home
- QQQX vs NEO Comparison
QQQX vs NEO Comparison
Compare QQQX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QQQX
- NEO
- Stock Information
- Founded
- QQQX 2007
- NEO 2001
- Country
- QQQX United States
- NEO United States
- Employees
- QQQX N/A
- NEO N/A
- Industry
- QQQX Finance Companies
- NEO Precision Instruments
- Sector
- QQQX Finance
- NEO Health Care
- Exchange
- QQQX Nasdaq
- NEO Nasdaq
- Market Cap
- QQQX 1.3B
- NEO 1.2B
- IPO Year
- QQQX N/A
- NEO 1999
- Fundamental
- Price
- QQQX $28.08
- NEO $10.61
- Analyst Decision
- QQQX
- NEO Buy
- Analyst Count
- QQQX 0
- NEO 10
- Target Price
- QQQX N/A
- NEO $12.56
- AVG Volume (30 Days)
- QQQX 127.6K
- NEO 5.0M
- Earning Date
- QQQX 01-01-0001
- NEO 10-28-2025
- Dividend Yield
- QQQX 7.03%
- NEO N/A
- EPS Growth
- QQQX N/A
- NEO N/A
- EPS
- QQQX N/A
- NEO N/A
- Revenue
- QQQX N/A
- NEO $689,189,000.00
- Revenue This Year
- QQQX N/A
- NEO $10.40
- Revenue Next Year
- QQQX N/A
- NEO $10.11
- P/E Ratio
- QQQX N/A
- NEO N/A
- Revenue Growth
- QQQX N/A
- NEO 9.70
- 52 Week Low
- QQQX $20.27
- NEO $4.72
- 52 Week High
- QQQX $25.99
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- QQQX 66.16
- NEO 70.26
- Support Level
- QQQX $27.52
- NEO $10.14
- Resistance Level
- QQQX $27.74
- NEO $10.89
- Average True Range (ATR)
- QQQX 0.41
- NEO 0.39
- MACD
- QQQX 0.03
- NEO 0.07
- Stochastic Oscillator
- QQQX 97.26
- NEO 86.20
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek an attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.